Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 312
Filtrar
1.
Vet Res ; 51(1): 116, 2020 Sep 14.
Artículo en Inglés | MEDLINE | ID: mdl-32928304

RESUMEN

Biomedical research relies on the use of animal models, and the animals used in those models receive medical care, including antibiotics for brief periods of time to treat conditions such as dermatitis, fight wounds, and suspected bacterial pathogens of unknown etiology. As many mouse model phenotypes are sensitive to changes in the gut microbiota, our goal was to examine the effect of antibiotics commonly administered to mice. Therefore, four treatment groups (subcutaneous enrofloxacin for 7 days, oral enrofloxacin for 14 days, oral trimethoprim-sulfamethoxazole for 14 days, and topical triple antibiotic ointment for 14 days) alongside a fifth control group receiving no treatment (n = 12/group) were included in our study. Fecal samples were collected prior to treatment, immediately after two weeks of exposure, and four weeks after cessation of treatment, and subjected to 16S rRNA library sequencing. The entire experimental design was replicated in mice from two different suppliers. As expected, several treatments including enrofloxacin and triple antibiotic ointment substantially decreased the amount of DNA recovered from fecal material, as well as the microbial richness. Notably, many of these effects were long-lasting with diminished gut microbiota (GM) richness four weeks following exposure, in both substrains of mice. Trimethoprim-sulfamethoxazole induced minimal to no discernible changes in the taxonomic composition beyond that seen in control mice. Collectively, these data highlight the need to consider the impact on GM of brief and seemingly routine use of antibiotics in the clinical care of research animals.


Asunto(s)
Antibacterianos/administración & dosificación , Bacitracina/administración & dosificación , Enrofloxacina/administración & dosificación , Heces/microbiología , Microbiota/efectos de los fármacos , Neomicina/administración & dosificación , Polimixinas/administración & dosificación , Combinación Trimetoprim y Sulfametoxazol/administración & dosificación , Administración Oral , Administración Tópica , Animales , Femenino , Inyecciones Subcutáneas/veterinaria , Ratones , Ratones Endogámicos C57BL , Pomadas/administración & dosificación
2.
N Z Vet J ; 68(2): 126-133, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31608795

RESUMEN

Case history: Gradual onset of ocular opacity was observed in three gold-striped geckos (Woodworthia chrysosiretica), and five Pacific geckos (Dactylocnemis pacificus) held in two adjacent terrariums in a zoological institution located in the North Island of New Zealand. Ultraviolet light and heat had been provided for the previous 3-4 years by a fluorescent bulb, but in the last 4 weeks of winter a ceramic heat bulb had been added, situated 10 cm above the upper mesh of the cageClinical findings: All eight geckos presented with mostly bilateral lesions of varying severity confined to the central or upper quadrant of the spectacles. These lesions ranged from variable areas of opacity within the stroma of the spectacle to similarly distributed ulcers of the surface epithelium of both spectacles. The spectacle lesions in the Pacific geckos responded well to treatment with topical combined antimicrobial therapy, within 18-29 days. The gold-striped geckos suffered complications including dysecdysis, severe spectacle ulceration and perforation, mycotic spectaculitis, and widespread mycotic dermatitis resulting in death or leading to euthanasia.Pathological findings: In the three gold-striped geckos, there were extensive areas of deep ulceration and replacement of the spectacle with a thick serocellular crust containing large numbers of fungal elements. The affected areas of the stroma were expanded by large deposits of proteinaceous and mucinous material, pyknotic cellular debris and moderate numbers of heterophils and macrophages as well as infiltrating fungal hyphae.Diagnosis: Mycotic spectaculitis with ulceration and perforation, and disseminated mycotic dermatitis likely secondary to thermal burns.Clinical relevance: This is the first report of thermal burns of the spectacle in any reptile. There was species variation in the burn severity with gold-striped geckos showing more severe lesions, possibly due to a mix of behavioural and anatomical factors. The thermal burns to the spectacles in three cases were complicated by delayed healing, perforation, dysecdysis and severe mycotic infection.


Asunto(s)
Quemaduras/veterinaria , Oftalmopatías/veterinaria , Calefacción/instrumentación , Vivienda para Animales , Lagartos , Animales , Animales de Zoológico , Antiinfecciosos/administración & dosificación , Antiinfecciosos/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Bacitracina/administración & dosificación , Bacitracina/uso terapéutico , Quemaduras/etiología , Combinación de Medicamentos , Oftalmopatías/etiología , Oftalmopatías/patología , Meloxicam/uso terapéutico , Neomicina/administración & dosificación , Neomicina/uso terapéutico , Polimixina B/administración & dosificación , Polimixina B/uso terapéutico , Rayos Ultravioleta
3.
Adv Skin Wound Care ; 33(4): 217-220, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32195725

RESUMEN

OBJECTIVE: To compare the efficacy of three topical agents commonly used in cutaneous wound healing. METHODS: Wound healing was studied in 29 participants, and each participant served as his or her own control. In each participant, three similarly sized and located seborrheic keratoses were removed by curettage. Resultant wounds were treated with either trolamine emulsion, manuka honey gel, or polymyxin-bacitracin ointment until the wounds were fully healed. RESULTS: Wounds treated with trolamine emulsion healed significantly faster than wounds treated with either manuka honey or polymyxin-bacitracin (15 vs 19 days; P < .001). CONCLUSIONS: Trolamine emulsion may be preferred in clinical practice to accelerate the healing time of clean, shallow wounds.


Asunto(s)
Bacitracina/administración & dosificación , Etanolaminas/administración & dosificación , Miel , Polimixina B/administración & dosificación , Piel/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Administración Cutánea , Emulsiones/administración & dosificación , Geles/administración & dosificación , Humanos , Pomadas/administración & dosificación , Piel/lesiones , Resultado del Tratamiento
4.
Ann Allergy Asthma Immunol ; 122(5): 502-507, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30851460

RESUMEN

BACKGROUND: Patch testing is the "gold standard" to identify culprit allergen(s) causing allergic contact dermatitis (ACD), but there are limited studies of patch testing from allergy practice settings. OBJECTIVE: We sought to explore patch test findings in a large academic allergy practice, including patch testing results, history of atopy, location of dermatitis, and referral source. We also wanted to determine whether patch testing using an extended panel, such as the North American screening series, compared with a limited series, such as the Thin-Layer Rapid-Use Epicutaneous (T.R.U.E.) Test, increased the sensitivity. METHODS: A retrospective chart review was conducted of patients referred for patch testing over a 6-year period. RESULTS: A total of 585 patients (mean age 48.7 years, 71.6 % female) underwent patch testing over the 6-year period, of which 369 (63%) had a positive test. Of those who tested positive, 202 (55%) reported a history of atopy. The extremities were the most commonly involved site, followed by the head/neck and trunk. The 5 most common positive allergens were nickel sulfate, gold sodium thiosulfate, methylchloroisothiazolinone, thimerosal, and bacitracin. Three hundred fourteen (53.6%) patients were positive to at least 1 allergen on TRUE testing. Extended screening series identified an additional 10.8% of patients with positive tests who were negative to T.R.U.E. test allergens. CONCLUSION: Patch testing is a valuable diagnostic tool for the practicing allergist and provides early identification of culprit allergens in ACD. Performing an extended screening series such as the North American Contact Dermatitis Group (NACDG) or supplemental panel of allergens increased sensitivity when compared with a limited series.


Asunto(s)
Alérgenos/administración & dosificación , Dermatitis Alérgica por Contacto/diagnóstico , Pruebas del Parche , Piel/efectos de los fármacos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Bacitracina/administración & dosificación , Niño , Preescolar , Dermatitis Alérgica por Contacto/inmunología , Dermatitis Alérgica por Contacto/fisiopatología , Femenino , Tiosulfato Sódico de Oro/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Níquel/administración & dosificación , Estudios Retrospectivos , Piel/inmunología , Piel/fisiopatología , Tiazoles/administración & dosificación , Timerosal/administración & dosificación
5.
Anal Bioanal Chem ; 411(1): 147-156, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30377739

RESUMEN

A high-throughput matrix-assisted laser desorption/ionization mass spectrometry (MALDI)-MS-based metabolomics platform was developed using a pre-fabricated microarray of nanoparticles and organic matrices. Selected organic matrices, inorganic nanoparticle (NP) suspensions, and sputter coated metal NPs, as well as various additives, were tested for metabolomics analysis of the turkey gut microbiome. Four NPs and one organic matrix were selected as the optimal matrix set: α-cyano-4-hydroycinnamic acid, Fe3O4 and Au NPs in positive ion mode with 10 mM sodium acetate, and Cu and Ag NPs in negative ion mode with no additive. Using this set of five matrices, over two thousand unique metabolite features were reproducibly detected across intestinal samples from turkeys fed a diet amended with therapeutic or sub-therapeutic antibiotics (200 g/ton or 50 g/ton bacitracin methylene disalicylate (BMD), respectively), or non-amended feed. Among the thousands of unique features, 56 of them were chemically identified using MALDI-MS/MS, with the help of in-parallel liquid chromatography (LC)-MS/MS analysis. Lastly, as a proof of concept application, this protocol was applied to 52 turkey cecal samples at three different time points from the antibiotic feed trial. Statistical analysis indicated variations in the metabolome of turkeys with different ages or treatments. Graphical abstract ᅟ.


Asunto(s)
Antibacterianos/administración & dosificación , Bacitracina/administración & dosificación , Ensayos Analíticos de Alto Rendimiento/métodos , Intestinos/microbiología , Metabolómica , Microbiota , Nanopartículas/química , Salicilatos/administración & dosificación , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , Pavos/microbiología , Animales , Cromatografía Liquida/métodos , Cobre/química , Ácidos Cumáricos/química , Relación Dosis-Respuesta a Droga , Óxido Ferrosoférrico/química , Oro/química , Estructuras Metalorgánicas , Prueba de Estudio Conceptual , Reproducibilidad de los Resultados , Plata/química , Espectrometría de Masas en Tándem/métodos
6.
Pediatr Emerg Care ; 35(12): e234-e235, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30702643

RESUMEN

We present an illustrative case of unintentional burns to the feet of a 15-month-old child following the application of raw garlic as a home remedy for fever. We provide an overview of the historical medicinal uses of garlic as well as its unintended adverse effects. This case underscores the importance of clinicians' ability to recognize unusual presentations of injury due to culturally based practices that require care in emergency settings. This is particularly important in patient populations for whom abusive etiology would be considered.


Asunto(s)
Quemaduras Químicas/patología , Fiebre/terapia , Traumatismos de los Pies/inducido químicamente , Ajo/efectos adversos , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Bacitracina/administración & dosificación , Bacitracina/uso terapéutico , Vendajes/normas , Quemaduras Químicas/tratamiento farmacológico , Quemaduras Químicas/etiología , Femenino , Fiebre/complicaciones , Traumatismos de los Pies/patología , Humanos , Lactante , Medicina Tradicional/efectos adversos , Fenoles/administración & dosificación , Resultado del Tratamiento
7.
J Anim Physiol Anim Nutr (Berl) ; 103(1): 72-86, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30485573

RESUMEN

The purpose of this study was to verify the ability of a probiotic in the feed to maintain the stability of the gut microbiota in chickens after antibiotic therapy and its association with growth performance. One thousand six hundred twenty 1-day-old Cobb male were housed in floor pens (36 pens, 45 birds/pen) and were fed corn-/soya bean meal-based diets supplemented with or without probiotic (Bacillus subtilis) during the entire rearing phase. From 21 to 24 days of age (three consecutive days), the chickens were submitted to antibiotic therapy via drinking water (bacitracin and neomycin) in order to mimic a field treatment and induce dysbiosis. Growth performance was monitored until 42 days of age. At 2, 4 and 6 days after antibiotic therapy, three chickens from each pen were euthanized and the contents of the small intestine and caeca were collected and pooled. The trial was conducted with four treatments and nine replicates in a 2 × 2 factorial arrangement for performance characteristics (with and without probiotic × with and without antibiotic therapy); for the intestinal microbiota, it was in a 2 × 2 × 3 factorial arrangement (with and without probiotic × with and without antibiotic therapy × 2, 4 and 6 days after the antibiotic therapy) with three replicates per treatment. Terminal restriction length polymorphism (T-RFLP) analysis showed that the structure of gut bacterial community was shaped by the intestinal segment and by the time after the antibiotic therapy. The number of 16S rDNAs copies in caecum contents decreased with time after the therapeutic treatment. The antibiotic therapy and dietary probiotic supplementation decreased richness and diversity indexes in the caecal contents. The improved performance observed in birds supplemented with probiotic may be related to changes promoted by the feed additive in the structure of the intestinal bacterial communities and phylogenetic groups. Antibiotic therapy modified the bacterial structure, but did not cause loss of broiler performance.


Asunto(s)
Alimentación Animal/análisis , Bacitracina/farmacología , Pollos/crecimiento & desarrollo , Microbioma Gastrointestinal/efectos de los fármacos , Neomicina/farmacología , Probióticos/farmacología , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Bacitracina/administración & dosificación , Pollos/microbiología , Dieta/veterinaria , Neomicina/administración & dosificación , Distribución Aleatoria
8.
N Engl J Med ; 370(8): 723-33, 2014 Feb 20.
Artículo en Inglés | MEDLINE | ID: mdl-24552319

RESUMEN

BACKGROUND: Recent guidance for the management of acute otorrhea in children with tympanostomy tubes is based on limited evidence from trials comparing oral antibiotic agents with topical antibiotics. METHODS: In this open-label, pragmatic trial, we randomly assigned 230 children, 1 to 10 years of age, who had acute tympanostomy-tube otorrhea to receive hydrocortisone-bacitracin-colistin eardrops (76 children) or oral amoxicillin-clavulanate suspension (77) or to undergo initial observation (77). The primary outcome was the presence of otorrhea, as assessed otoscopically, 2 weeks after study-group assignment. Secondary outcomes were the duration of the initial otorrhea episode, the total number of days of otorrhea and the number of otorrhea recurrences during 6 months of follow-up, quality of life, complications, and treatment-related adverse events. RESULTS: Antibiotic-glucocorticoid eardrops were superior to oral antibiotics and initial observation for all outcomes. At 2 weeks, 5% of children treated with antibiotic-glucocorticoid eardrops had otorrhea, as compared with 44% of those treated with oral antibiotics (risk difference, -39 percentage points; 95% confidence interval [CI], -51 to -26) and 55% of those treated with initial observation (risk difference, -49 percentage points; 95% CI, -62 to -37). The median duration of the initial episode of otorrhea was 4 days for children treated with antibiotic-glucocorticoid eardrops versus 5 days for those treated with oral antibiotics (P<0.001) and 12 days for those who were assigned to initial observation (P<0.001). Treatment-related adverse events were mild, and no complications of otitis media, including local cellulitis, perichondritis, mastoiditis, and intracranial complications, were reported at 2 weeks. CONCLUSIONS: Antibiotic-glucocorticoid eardrops were more effective than oral antibiotics and initial observation in children with tympanostomy tubes who had uncomplicated acute otorrhea. (Funded by the Netherlands Organization for Health Research and Development; Netherlands Trial Register number, NTR1481.).


Asunto(s)
Antibacterianos/administración & dosificación , Glucocorticoides/administración & dosificación , Ventilación del Oído Medio/efectos adversos , Otitis Media con Derrame/tratamiento farmacológico , Administración Oral , Administración Tópica , Combinación Amoxicilina-Clavulanato de Potasio/administración & dosificación , Antibacterianos/efectos adversos , Bacitracina/administración & dosificación , Niño , Preescolar , Colistina/administración & dosificación , Combinación de Medicamentos , Femenino , Glucocorticoides/efectos adversos , Humanos , Hidrocortisona/administración & dosificación , Lactante , Estimación de Kaplan-Meier , Masculino , Otitis Media con Derrame/etiología , Otitis Media con Derrame/cirugía
9.
Poult Sci ; 95(2): 247-60, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26567176

RESUMEN

The etiological agent of necrotic enteritis (NE) is Clostridium perfringens (CP), which is an economically significant problem for broiler chicken producers worldwide. Traditional use of in-feed antibiotic growth promoters to control NE disease have resulted in the emergence of antibiotic resistance in CP strains. Identification of probiotic bacteria strains as an alternative to antibiotics for the control of intestinal CP colonization is crucial. Two experiments were conducted to determine changes in intestinal bacterial assemblages in response to CP infection and in-feed bacitracin methylene disalicylate (BMD) in broiler chickens. In each experiment conducted in battery-cage or floor-pen housing, chicks were randomly assigned to the following treatment groups: 1) BMD-supplemented diet with no CP challenge (CM), 2) BMD-free control diet with no CP challenge (CX), 3) BMD-supplemented diet with CP challenge (PCM), or 4) BMD-free control diet with CP challenge (PCX). The establishment of CP infection was confirmed, with the treatment groups exposed to CP having a 1.5- to 2-fold higher CP levels (P < 0.05) compared to the non-exposed groups. Next-generation sequencing of PCR amplified 16S rRNA genes, was used to perform intestinal bacterial diversity analyses pre-challenge, and at 1, 7, and 21 d post-challenge. The results indicated that the intestinal bacterial assemblage was dominated by members of the phylum Firmicutes in all treatments before and after CP challenge, especially the Lactobacillaceae and Clostridiales families. In addition, we observed post-challenge emergence of members of the Enterobacteriaceae and Streptococcaceae in the non-medicated PCX treatment, and emergence of the Enterococcaceae in the medicated PCM treatment. This study highlights the bacterial interactions that could be important in suppressing or eliminating CP infection within the chicken intestine. Future studies should explore the potential to use commensal strains of unknown Clostridiales, Lactobacillaceae, Enterobacteriaceae, Streptococcaceae, and Enterococcaceae in effective probiotic formulations for the control of CP and NE disease.


Asunto(s)
Antiinfecciosos/farmacología , Bacitracina/farmacología , Pollos , Infecciones por Clostridium/veterinaria , Microbioma Gastrointestinal/efectos de los fármacos , Reacción en Cadena de la Polimerasa/veterinaria , Enfermedades de las Aves de Corral/tratamiento farmacológico , Alimentación Animal/análisis , Animales , Antiinfecciosos/administración & dosificación , Bacitracina/administración & dosificación , Infecciones por Clostridium/tratamiento farmacológico , Infecciones por Clostridium/microbiología , Clostridium perfringens/efectos de los fármacos , Clostridium perfringens/fisiología , ADN Bacteriano/análisis , Dieta/veterinaria , Suplementos Dietéticos/análisis , Masculino , Enfermedades de las Aves de Corral/microbiología , ARN Ribosómico 16S/análisis , Distribución Aleatoria
10.
J Anim Physiol Anim Nutr (Berl) ; 100(3): 485-91, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26608478

RESUMEN

A total of 336 one-day-old Hubbard broiler chickens were randomly distributed among 8 groups, each containing six replicates (7 chickens/replicate). From 1 to 40 days of age, the groups fed the same starter, grower and finisher diets. The control group was unsupplemented; zinc bacitracin (ZnB) group received the antibiotic at 0.5 g/kg; fungal phytase (FP) groups received 250, 500 and 1000 U/kg diet of Aspergillus niger phytase (FP_250, FP_500 and FP_1000 groups), respectively; bacterial phyatse (BP) groups received 250, 500 and 1000 U/kg diet of Escherichia coli phytase (BP_250EP, BP_500EP and BP_1000EP groups) respectively. Considering the whole experimental period, body weight gain was unaffected by ZnB and different concentrations of bacterial and fungal phytase; however, the feed conversion ratio of the group fed a diet supplemented with 500 U of BP was better (p < 0.01) than those fed with a diet supplemented with 500 U of FP. BP_250 group had a higher (p < 0.05) apparent digestibility of ether extract compared to FP_250 group. In conclusion, bacterial phytase at 500 U may enhance performance of broiler chickens fed during days 1-40 of age and yield similar growth performance and economic efficiency to those of eB-supplemented groups.


Asunto(s)
6-Fitasa/farmacología , Antibacterianos/farmacología , Bacitracina/farmacología , Digestión/efectos de los fármacos , Carne/normas , 6-Fitasa/administración & dosificación , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Antibacterianos/administración & dosificación , Aspergillus niger/enzimología , Bacitracina/administración & dosificación , Pollos/crecimiento & desarrollo , Dieta/veterinaria , Digestión/fisiología , Ingestión de Alimentos/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Escherichia coli/enzimología , Femenino , Masculino , Aumento de Peso/efectos de los fármacos
11.
Pak J Pharm Sci ; 29(6 Suppl): 2287-2291, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28167467

RESUMEN

Atopic dermatitis (AD) commonly identified as eczema. AD is an inflammatory, long-lasting, highly pruritic reverting disease of the skin. AD is classified by disease of outer skin layer barrier function. AD is progress with Immunoglobulin E facilitated sensitization to food and environmental allergens. One study stated that more than 59.6% of teen-agers with AD are at high risk of develop asthma or rhinitis. Interaction between genes and environment increase the prevalence of AD. AD have three standard stages: infantile, childhood, and adulthood. AD sign and symptoms diverge extensively. AD can be present that simply affect the hand to where a patient presents with erythroderma. AD present with erythematous papules, extremely pruritic with serous exudate. Lichenified plaques and papules are symptoms of long lasting AD. Due to outer skin layer barrier dysfunction bacterial and viral infection risk is increased in AD patients. This study was directed on 100 patients in which 50 are PolymixinB-bacitrin group and 50 are Dermidoc group. Patients were selected after seeing inclusion and exclusion criteria and taking written informed consent. Dermidoc group expressively amended skin symptoms associated with AD comparing to the PolymixinB-bacitrin group. The Dermidoc cream is effective and well tolerated. The results were analysis using paired sample t-test. The p value is <0.05. Test group (Dermidoc) were significantly more effective than PolymixinB-bacitrin group.


Asunto(s)
Antiinfecciosos Locales/administración & dosificación , Bacitracina/administración & dosificación , Dermatitis Atópica/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Preparaciones de Plantas/administración & dosificación , Polimixina B/administración & dosificación , Piel/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Administración Cutánea , Adolescente , Adulto , Antiinfecciosos Locales/efectos adversos , Bacitracina/efectos adversos , Niño , Preescolar , Dermatitis Atópica/diagnóstico , Femenino , Humanos , Masculino , Extractos Vegetales/efectos adversos , Preparaciones de Plantas/efectos adversos , Polimixina B/efectos adversos , Piel/patología , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
12.
Gastrointest Endosc ; 91(3): 714-715, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-31520590

Asunto(s)
Abdomen Agudo , Endoscopía/métodos , Fístula Gástrica/cirugía , Pancreatitis , Abdomen/diagnóstico por imagen , Abdomen/cirugía , Abdomen Agudo/etiología , Abdomen Agudo/cirugía , Abdomen Agudo/terapia , Enfermedad Aguda , Adulto , Fuga Anastomótica/terapia , Antibacterianos/administración & dosificación , Ascitis/complicaciones , Bacitracina/administración & dosificación , Contraindicaciones , Desbridamiento , Derivación Gástrica/efectos adversos , Fístula Gástrica/diagnóstico , Fístula Gástrica/terapia , Tracto Gastrointestinal/irrigación sanguínea , Tracto Gastrointestinal/patología , Humanos , Infusiones Parenterales , Isquemia/etiología , Cirrosis Hepática/complicaciones , Masculino , Enfermedad del Hígado Graso no Alcohólico/complicaciones , Fístula Pancreática/diagnóstico , Fístula Pancreática/etiología , Fístula Pancreática/terapia , Jugo Pancreático , Pancreatitis/complicaciones , Pancreatitis/diagnóstico por imagen , Pancreatitis/cirugía , Pancreatitis/terapia , Pancreatitis Aguda Necrotizante/complicaciones , Pancreatitis Aguda Necrotizante/diagnóstico , Pancreatitis Aguda Necrotizante/cirugía , Pancreatitis Aguda Necrotizante/terapia , Úlcera Péptica Perforada/diagnóstico , Úlcera Péptica Perforada/etiología , Úlcera Péptica Perforada/terapia , Cavidad Peritoneal/diagnóstico por imagen , Cavidad Peritoneal/cirugía , Implantación de Prótesis , Recurrencia , Stents Metálicos Autoexpandibles , Circulación Esplácnica , Irrigación Terapéutica , Trombosis/etiología
13.
J Appl Microbiol ; 119(6): 1515-26, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26425940

RESUMEN

AIMS: The purpose of this study was to compare the effects of feeding virginiamycin or bacitracin methylene disalicylate (BMD), two in-feed antibiotics typically used by commercial poultry producers in the United States, on the chicken gastrointestinal microbiota. METHODS AND RESULTS: 454 pyrosequencing of the V6-V8 region of the 16S rRNA gene and quantitative PCR were employed to examine the bacterial microbiota and Clostridium perfringens, respectively, in the jejunum and caecum of market-age broiler chickens over four replicate grow-outs. CONCLUSIONS: Our results suggest that virginiamycin has a more pronounced impact on broiler gastrointestinal tract bacterial communities, relative to BMD, manifested primarily through significant enrichments in the genus Faecalibacterium in the caecum and a distinct population of Lactobacillus, OTU_02, in both the jejunum and caecum. No evidence for a difference among the diets in Cl. perfringens levels in the jejunum or caecum was observed. SIGNIFICANCE AND IMPACT OF THE STUDY: This work represents the highest resolution comparison to date of the jejunum and caecum microbiota in broilers fed either virginiamycin or BMD, and provides evidence for specific bacterial OTUs potentially involved in the health and performance benefits typically attributed to these in-feed antibiotics.


Asunto(s)
Antibacterianos/farmacología , Bacitracina/farmacología , Bacterias/efectos de los fármacos , Microbioma Gastrointestinal/efectos de los fármacos , Intestinos/microbiología , Salicilatos/farmacología , Virginiamicina/farmacología , Administración Oral , Animales , Antibacterianos/administración & dosificación , Bacitracina/administración & dosificación , Pollos , Salicilatos/administración & dosificación , Virginiamicina/administración & dosificación
14.
Poult Sci ; 94(11): 2630-4, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26362978

RESUMEN

The effect of dietary thyme-oil extract (TOE) supplementation on immune functions of broilers were assessed by feeding graded levels (50, 100, 200, or 400 ppm) of TOE to male broiler chicks during a 42-d feeding trial compared with negative- or positive-control diets. Dietary control treatments included a negative-control diet with no feed-additive supplementation and 2 positive-control groups supplemented with either virginiamycin or zinc bacitracin. In total, 300 1-day-old Ross × Ross male broilers were randomly assigned to 6 dietary treatments that consisted of 5 replicates of 10 birds each. On d 21 and 42, 2 birds from each replicate were killed by cervical cutting to measure the relative weights of spleen and bursa of Fabricius. At 25 d of age, chicks were injected with 0.5 mL of 10% SRBC suspension. Broilers fed with 200 ppm of TOE had heavier weights of bursa of Fabricius than those fed other dietary treatments at d 42 of age. Furthermore, dietary inclusion of 100 ppm of TOE resulted in higher (P < 0.05) total immunoglobulin response in primary antibody titer against sheep erythrocytes compared with other dietary treatments. On the other hand, diet modifications had no significant effect on blood leukocyte subpopulations and heterophil-to-lymphocyte ratio. These results suggest that dietary supplementation with TOE, especially at the level of 100 ppm, can improve immunological responses of broiler chicks.


Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Animales/efectos de los fármacos , Formación de Anticuerpos , Pollos/inmunología , Extractos Vegetales/farmacología , Thymus (Planta)/química , Alimentación Animal/análisis , Animales , Bacitracina/administración & dosificación , Dieta/veterinaria , Suplementos Dietéticos/análisis , Masculino , Virginiamicina/administración & dosificación
15.
Aesthet Surg J ; 34(4): 560-70, 2014 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-24682442

RESUMEN

BACKGROUND: Nipple-sparing mastectomy performed via an inframammary fold incision with implant-based reconstruction is an oncologically safe procedure that provides excellent cosmesis. OBJECTIVES: The authors report their experience with conservative treatment of postoperative nipple-areolar complex (NAC) ischemia and an analysis of risk factors for NAC ischemia and conservative treatment failure. METHODS: A retrospective chart review was conducted of 318 nipple-sparing mastectomies performed through inframammary fold incisions with implant-based reconstruction between July 2006 and October 2012. NAC dressings consisted of topical nitroglycerin, external warming for 24 hours, antibacterial petrolatum gauze, and a loose bra for 1 week. Patients were monitored for NAC ischemia as the primary endpoint. NAC ischemia was treated with bacitracin ointment. In cases of full-thickness ischemia, expanders were also partially deflated. RESULTS: Partial- and full-thickness NAC ischemia occurred in 44 (13.8%) and 21 (6.6%) cases, respectively. All partial- and 17 full-thickness cases resolved with conservative treatment. Of these, 7 partial- and 2 full-thickness cases suffered residual depigmentation. Four full-thickness cases required operative debridement. Factors associated with NAC ischemia included increasing age (P = .035), higher body mass index (P = .0009), greater breast volume (P = .0023), and diabetes (P = .0046). Factors associated with conservative treatment failure included increasing age (P < .0001), higher body mass index (P = .014), greater breast volume (P = .020), smoking (P = .0449), acellular dermal matrix use (P < .0001), and single-stage reconstruction (P = .0090). CONCLUSIONS: Postoperative NAC ischemia can be effectively managed conservatively to preserve cosmesis and implant viability. Knowledge of risk factors for NAC ischemia and conservative treatment failure may improve future patient counseling and outcomes.


Asunto(s)
Implantación de Mama/efectos adversos , Isquemia/etiología , Mastectomía Subcutánea/efectos adversos , Pezones/irrigación sanguínea , Pezones/cirugía , Administración Cutánea , Adulto , Anciano , Antibacterianos/administración & dosificación , Bacitracina/administración & dosificación , Femenino , Humanos , Isquemia/diagnóstico , Isquemia/tratamiento farmacológico , Persona de Mediana Edad , Pomadas , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento
16.
Poult Sci ; 103(5): 103604, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38484563

RESUMEN

The poultry industry is evolving towards antibiotic-free production to meet market demands and decelerate the increasing spread of the antimicrobial resistance. The growing need for antibiotic free products has challenged producers to decrease or completely stop using antimicrobials as feed supplements in broiler diet to improve feed efficiency, growth rate, and intestinal health. Natural feed additives (e.g., probiotics and phytobiotics) are promising alternatives to substitute antimicrobial growth promoters. The goal of our study was to characterize the effects of a Probiotic and an Essential Oils blend on broilers' performance and perform a time-series analysis to describe their excreta microbiome. A total of 320 Cobb 500 (1-day-old) chicks were raised for 21 d in 32 randomly allocated cages. Treatments consisted of 4 experimental diets: a basal diet, and a basal diet mixed with an Antibiotic (bacitracin methylene disalicylate), an essential oils blend (oregano oil, rosemary, and red pepper), or a Probiotic (Bacillus subtilis). Body weight (on 1, 10, and 21d), and feed intake (10d and 21d) were recorded and feed conversion ratio was calculated. Droppings were collected daily (1-21d) to characterize broilers' excreta microbiota by targeted sequencing of the bacterial 16S rRNA gene. The Probiotic significantly improved feed conversion ratio for starter phase 1 to 10d (P = 0.03), grower phase 10 to 21d (P = 0.05), and total period 1 to 21d (P = 0.01) compared to the Antibiotic. Feed supplements did not affect alpha diversity but did impact microbial beta diversity (P < 0.01). Age also impacted microbiome turnover as differences in alpha and beta diversity were detected. Furthermore, when compared to the basal diet, the probiotic and antibiotic significantly impacted relative abundance of Bifidobacterium (log2 fold change -1.44, P = 0.03), Intestinimonas (log2 fold change 0.560, P < 0.01) and Ligilactobacillus (log2 fold change -1.600, P < 0.01). Overall, Probiotic supplementation but not essential oils supplementation positively impacted broilers' growth performance by directly causing directional shifts in broilers' excreta microbiota structure.


Asunto(s)
Alimentación Animal , Antibacterianos , Pollos , Dieta , Suplementos Dietéticos , Aceites Volátiles , Probióticos , Salicilatos , Animales , Pollos/crecimiento & desarrollo , Pollos/microbiología , Alimentación Animal/análisis , Probióticos/administración & dosificación , Probióticos/farmacología , Dieta/veterinaria , Suplementos Dietéticos/análisis , Aceites Volátiles/administración & dosificación , Aceites Volátiles/farmacología , Antibacterianos/farmacología , Antibacterianos/administración & dosificación , Heces/microbiología , Microbioma Gastrointestinal/efectos de los fármacos , Bacitracina/farmacología , Bacitracina/administración & dosificación , Distribución Aleatoria , Bacillus subtilis/efectos de los fármacos , Microbiota/efectos de los fármacos , Masculino , Aceites de Plantas/farmacología , Aceites de Plantas/administración & dosificación
17.
Dermatol Surg ; 39(8): 1260-3, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23777421

RESUMEN

BACKGROUND: Although there is no universally accepted topical emollient recommended for wound care, there has been a trend toward minimizing exposure to common culprits of allergic contact dermatitis. OBJECTIVE: To assess the current practices of postoperative emollient use of dermatologic surgeons. METHODS AND MATERIALS: An anonymous 10-question survey on postoperative emollient use for clean surgical wounds was e-mailed to 857 members of the American College of Mohs Surgery. RESULTS: Two hundred ninety-four members (34.3%) responded. After routine closure, the most commonly used topical emollient placed immediately postoperatively was petroleum jelly (53.1%), followed by Aquaphor (Beiersdorf Inc., Wilton, CT) (19.4%) and bacitracin (8.2%) (p < .001). Respondents recommended that patients use the following topical emollients at home to keep the wound moist: petroleum jelly (69.4%), Aquaphor (38.4%), bacitracin (10.0%), mupirocin (9.2%), polymyxin (8.8%), neomycin (2.0%), and gentamicin (1.0%) (p < .001). The three most common topical emollients that were requested not to be used were neomycin (92.8%), polymyxin (44.3%), and bacitracin (44.3%) (p < .001). CONCLUSION: Although emollients with low risk for contact allergy such as petroleum jelly are used more frequently, topical antimicrobials with known sensitizing potential are being applied and recommended for clean surgical wounds. A change in practice is needed to avoid these allergens.


Asunto(s)
Emolientes/administración & dosificación , Cirugía de Mohs , Administración Tópica , Bacitracina/administración & dosificación , Humanos , Vaselina/administración & dosificación , Cuidados Posoperatorios , Pautas de la Práctica en Medicina , Cicatrización de Heridas/efectos de los fármacos
18.
J Drugs Dermatol ; 12(5): 558-61, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23652951

RESUMEN

OBJECTIVES: To determine the effectiveness of HP802-247 compared with bacitracin ointment in healing wounds resulting from Mohs micrographic surgery. METHODS: Open-label, randomized pilot study conducted at a single center. Subjects were randomized to either HP802-247 (5M cells/mL) applied weekly or bacitracin ointment applied daily. Treatment continued for up to 12 weeks or complete wound closure. Primary efficacy was effectiveness as measured by the Investigator's Global Assessment of Healing (IGAH) scale. Secondary outcomes included median time to healing, investigator- and subject-scored signs and symptoms, and an assessment of scar by the investigator at 16 weeks postsurgery. RESULTS: All subjects achieved favorable outcomes within the study period; however, these were reached more quickly for the HP802-247 group than for bacitracin. At 3 weeks postsurgery, healing was assessed as very effective for 75% of subjects in the HP802-247 group compared with 50% for bacitracin. Median time to closure was 24.5 days for HP802-247 and 29 days for bacitracin. Scores for signs and symptoms and scar were similar for both groups but, in general, were numerically better for HP802-247. CONCLUSION: In this small pilot study, HP802-247 was found to provide a modest, incremental benefit in the healing of Mohs micrographic surgery wounds, suggesting that the healing of uncomplicated acute wounds may be slightly accelerated without enhancement of scarring.


Asunto(s)
Bacitracina/farmacología , Fibrina/farmacología , Cirugía de Mohs/métodos , Cicatrización de Heridas/efectos de los fármacos , Anciano , Anciano de 80 o más Años , Bacitracina/administración & dosificación , Cicatriz/patología , Femenino , Fibrina/administración & dosificación , Fibroblastos/metabolismo , Estudios de Seguimiento , Humanos , Queratinocitos/metabolismo , Masculino , Persona de Mediana Edad , Proyectos Piloto , Factores de Tiempo , Resultado del Tratamiento
19.
Br Poult Sci ; 54(2): 238-46, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23647188

RESUMEN

1. The addition of yeast cell wall (YCW) mannan fractions or low concentrations of antibiotics to the diet of broilers positively affects gut health by improving intestinal cell morphology and improves feed efficiency and performance; however the exact mechanisms are unclear. Based on these production responses, the objective of this study was to compare the effects of supplementing YCW and bacitracin methylene disalicylate (BMD) in the diet on mRNA levels in the jejunum of 6-week-old broilers. 2. Dietary treatments were a maize-soya control diet and the control diet with the addition of YCW or BMD. Birds (n = 7) from each dietary treatment were randomly selected and killed at d 42. Whole jejunum (with serosa) samples were collected for RNA isolation. Gene expression analysis was performed using the AffymetrixGeneChip Chicken Genome Array (Santa Clara, CA, USA). 3. Supplementation with YCW resulted in 928 genes that were significantly changed (456 down-regulated, 472 up-regulated) and supplementation with BMD resulted in 857 genes that significantly changed (408 down-regulated, 449 up-regulated). In addition, 316 genes were significantly changed by both YCW and BMD (146 down-regulated, 170 up-regulated). 4. BMD increased the expression of genes involved in lipid and carbohydrate metabolism and decreased expression of genes associated with T-helper cell pathways. Gene expression profiles from birds fed on diets containing YCW showed changes on a genomic level that correspond to slower gut cell turnover and therefore increased energy preservation for growth. 5. In conclusion, supplementation with BMD or YCW had similar influences on the number of differentially expressed genes in the jejunum. Biological functions common to both YCW and BMD with positive activation scores included antiviral response and antimicrobial response. Genes that were affected by BMD or YCW classified into both different and common biological functions and pathways related to improved metabolism and health in the jejunum.


Asunto(s)
Bacitracina/administración & dosificación , Pollos/fisiología , Yeyuno/metabolismo , Mananos/administración & dosificación , Prebióticos , Salicilatos/administración & dosificación , Transcriptoma , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Pared Celular/química , Pollos/genética , Dieta/veterinaria , Suplementos Dietéticos/análisis , Masculino , Análisis de Secuencia por Matrices de Oligonucleótidos/veterinaria , Oligosacáridos/administración & dosificación , Saccharomyces cerevisiae/química
20.
Antimicrob Agents Chemother ; 56(8): 4508-10, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22644024

RESUMEN

A wound biofilm model was created by adapting a superficial infection model. Partial-thickness murine wounds were inoculated with methicillin-resistant Staphylococcus aureus (MRSA). Dense biofilm communities developed at the wound surface after 24 h as demonstrated by microscopy and quantitative microbiology. Common topical antimicrobial agents had reduced efficacy when treatment was initiated 24 h after inoculation compared to 4 h after inoculation. This model provides a rapid in vivo test for new agents to treat wound biofilm infections.


Asunto(s)
Antiinfecciosos Locales/administración & dosificación , Biopelículas/efectos de los fármacos , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Infección de Heridas/microbiología , Administración Tópica , Animales , Antiinfecciosos Locales/farmacología , Bacitracina/administración & dosificación , Bacitracina/farmacología , Staphylococcus aureus Resistente a Meticilina/fisiología , Ratones , Mupirocina/administración & dosificación , Mupirocina/farmacología , Compuestos de Plata/administración & dosificación , Compuestos de Plata/farmacología , Sulfadiazina de Plata/administración & dosificación , Sulfadiazina de Plata/farmacología , Infección de Heridas/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA